Medicare billing address
CMS Medicare provider billing file
1380 E Medical Center Dr Ste 2100St George, UT 84790
CMS public data · NPI 1063687051
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Scott A Salmon, D.O.
Specialty
Credential
D.O.
NPI
1063687051
Primary source state
UT
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Scott A Salmon, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1380 E Medical Center Dr Ste 2100CMS Doctors & Clinicians file
1303 N Main StCMS Doctors & Clinicians file
1380 E Medical Ctr DrCMS Doctors & Clinicians file
1380 E Medical Ctr DrIn the 2024 CMS provider billing file, this NPI had 650 Medicare beneficiaries and 3,970 total services. The average beneficiary age was 75, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$262,153.86
Total Medicare payment amount
$194,003.28
Medicare beneficiaries
650
Total services
3,970
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
74%
CMS beneficiary-panel share
Hyperlipidemia
66%
CMS beneficiary-panel share
Diabetes
28%
CMS beneficiary-panel share
Ischemic heart disease
26%
CMS beneficiary-panel share
Chronic kidney disease
22%
CMS beneficiary-panel share
Atrial fibrillation
20%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 2,100 | $6.23 |
| Urinalysis, manual test | 299 | $3.41 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 294 | $87.27 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 271 | $122.30 |
| Diagnostic exam of bladder and urethra using an endoscope | 176 | $225.67 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 159 | $179.87 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 126 | $159.77 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 55 | $688.15 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $33.65 |
| Automated urinalysis test | 39 | $2.20 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1063687051. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 454 | 1,162.4 | $6,152.21 |
| 2 | Finasteride | Finasteride | 300 | 833.8 | $4,336.96 |
| 3 | Oxybutynin Chloride | Oxybutynin Chloride | 147 | 174 | $1,312.27 |
| 4 | Solifenacin Succinate | Solifenacin Succinate | 123 | 324.7 | $5,738.81 |
| 5 | Ciprofloxacin Hcl | Ciprofloxacin Hcl | 96 | 100 | $609.90 |
| 6 | Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 66 | 66 | $275.74 |
| 7 | Myrbetriq | Mirabegron | 25 | 57 | $29,405.76 |
| 8 | Doxazosin Mesylate | Doxazosin Mesylate | 22 | 38 | $350.73 |
| 9 | Bicalutamide | Bicalutamide | 19 | 19 | $254.86 |
| 10 | Potassium Citrate Er | Potassium Citrate | 18 | 48.7 | $1,248.07 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2008
Group/practice field
Ihc Health Services Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.